CoChat

Moclobemide upregulated Bcl‐2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular‐regulated kinase pathway

Open access
Chiou, Shih‐Hwa, Ku, Hung‐Hai, Tsai, Tung‐Hu, Lin, Heng‐Liang, Chen, Li‐Hsin, Chien, Chan‐Shiu, Ho, Larry L ‐T, Lee, Chen‐Hsen, Chang, Yuh‐Lih · 2006 · British Journal of Pharmacology
Cited by 74

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Moclobemide (MB) is an antidepressant drug that selectively and reversibly inhibits monoamine oxidase‐A. Recent studies have revealed that antidepressant drugs possess the characters of potent growth‐promoting factors for the development of neurogenesis and improve the survival rate of serotonin (5‐hydroxytrytamine; 5‐HT) neurons. However, whether MB comprises neuroprotection effects or modulates the proliferation of neural stem cells (NSCs) needs to be elucidated. In this study, firstly, we used the MTT (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide) assay to demonstrate that 50 μM MB can increase the cell viability of NSCs. The result of real‐time reverse transcription–polymerase chain reaction (RT–PCR) showed that the induction of MB can upregulate the gene expressions of Bcl‐2 and Bcl‐xL. By using caspases 8 and 3, ELISA and terminal dUTP nick‐end labeling (TUNEL) assay, our data further confirmed that 50 μM MB‐treated NSCs can prevent FasL‐induced apoptosis. The morphological findings also supported the evidence that MB can facilitate the dendritic development and increase the neurite expansion of NSCs. Moreover, we found that MB treatment increased the expression of Bcl‐2 in NSCs through activating the extracellular‐regulated kinase (ERK) phosphorylation. By using the triple‐staining immunofluorescent study, the percentages of serotonin‐ and MAP‐2‐positive cells in the day 7 culture of MB‐treated NSCs were significantly increased (P<0.01). Furthermore, our data supported that MB treatment increased functional production of serotonin in NSCs via the modulation of ERK1/2. In sum, the study results support that MB can upregulate Bcl‐2 expression and induce the differentiation of NSCs into serotoninergic neuron via ERK pathway. British Journal of Pharmacology (2006) 148, 587–598. doi:10.1038/sj.bjp.0706766

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0706766

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 74

Metadata

Authors
Chiou, S., Ku, H., Tsai, T., Lin, H., Chen, L., Chien, C., Ho, L. L. ‐., Lee, C., & Chang, Y.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2006-07
Volume
148
Issue
5
Pages
587-598
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2000865963
Cited by
74
References
11
FWCI
1.71
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Moclobemide upregulated Bcl‐2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular‐regulated kinase pathway. https://app.cochat.ai/papers/10.1038/sj.bjp.0706766
The paper
Chiou, S., Ku, H., Tsai, T., Lin, H., Chen, L., Chien, C., Ho, L. L. ‐., Lee, C., & Chang, Y. (2006). Moclobemide upregulated Bcl‐2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular‐regulated kinase pathway. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0706766

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.